Search

everythinglearnresearchcommunity

for

Search:↓

Three new gene mutations cause rickets and hair loss, treatable with high calcium and calcidol, but hair regrowth is rare.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Lowering homocyst(e)ine levels can reverse skin and hair lightening by restoring enzyme activity needed for pigmentation.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Certain amino acid analogues can inhibit wool and hair growth and affect fiber strength.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Neurosteroids may help treat disorders with too much dopamine activity.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Dutasteride is approved to help manage prostate enlargement.

Decanoic acid may help treat PCOS by reducing androgen levels and improving glucose sensitivity.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.